Navigation Links
Analysis Finds U.S. Medical-Surgical Manufacturers Using GHX Market Intelligence Grew Revenue Faster Than Non-Users in 2009

LOUISVILLE, Colo., July 29 /PRNewswire/ -- An analysis of medical-surgical sales through distribution conducted by GHX has found that among the top 100 U.S. medical-surgical manufacturers by dollar spend, those that use GHX Market Intelligence data grew medical-surgical revenue through distribution by an average of 6.42 percent in 2009, while non-users grew similarly classified revenue by an average of only 3.88 percent. Furthermore, GHX's analysis also found that those manufacturers employing more granular-level market data from GHX increased revenue at a faster rate than those using higher-level data.

GHX Market Intelligence tracks and reports on more than $35.5 billion of distributed sales for medical-surgical and clinical laboratory supplies and devices delivered from 27 of the nation's leading distributor members of the Health Industry Distributors Association (HIDA). Manufacturers use GHX Market Intelligence to better understand their market share compared to competitors, as well as growth opportunities by market and product.

GHX analyzed sales through distribution by dollars spent on medical-surgical products from the first quarter through the fourth quarter of 2009 and determined that GHX Market Intelligence users grew medical-surgical revenue through distribution faster than non-users during this time period. Other key findings of the GHX analysis include:

  • 90 percent (or 18) of the top 20 U.S. medical-surgical manufacturers by dollar spend use GHX Market Intelligence data to gain greater insights into the medical-surgical marketplace.
  • Among all manufacturers that use GHX Market Intelligence data, those that employ data down to the granular, three-digit ZIP code level grew their medical-surgical revenue through distribution by an average of 7.49 percent in 2009, while those that employ national-level data grew their similarly classified revenue by an average of 4.14 percent.

GHX Market Intelligence is a comprehensive source for accurate, detailed and timely data for the acute and alternate site healthcare markets, containing geographically relevant and competitive market share, size and average selling price reporting down to the three-digit ZIP code level. Leveraging GHX Market Intelligence data, medical-surgical manufacturers can better align resources, improve demand planning to meet customer needs, support distributor sales and target opportunities to drive revenue growth in new and existing markets.

"Top-performing medical device manufacturers have found that aligning sales efforts with available market opportunities is critical to success in today's challenging business environment," said Ed McCauley, vice president, E-Sourcing and Business Intelligence, GHX. "In the coming months, as manufacturers conduct sales planning and forecasting for next year, GHX Market Intelligence data will assist them in gaining a clearer understanding of the competitive landscape and help them identify where they can best invest their resources for maximum growth in 2011. We have seen more and more companies make this data an integral part of the planning process, and the results speak for themselves."

About GHX

As the business hub for healthcare, Global Healthcare Exchange, LLC (GHX) enables healthcare providers and suppliers in North America and Europe to reduce costs and improve margins by automating processes, reducing operating expenses and increasing knowledge-based decision making.  Products and services include trading partner connectivity, order and contract management and validation, data synchronization, sales force automation and business intelligence. Equity owners of GHX are Abbott Exchange, Inc.; AmerisourceBergen Corp.; Baxter Healthcare Corp.; B. Braun Medical Inc.; BD; Boston Scientific Corp.; Cardinal Health, Inc.; Covidien; C.R. Bard, Inc.; Thermo Fisher Scientific Inc.; GE Healthcare; HCA; Johnson & Johnson Health Care Systems Inc.; McKesson Corp.; Medtronic USA, Inc.; Owens & Minor; Premier, Inc.; Siemens; University HealthSystem Consortium; and VHA Inc.  For more information, visit

Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Sysmex America to Launch Complete Cell Image Analysis Portfolio at AACC
2. Reportlinker Adds Global Pharma-biotech Alliance Analysis
3. Dendreon Statement on CMS National Coverage Analysis
4. Information-Motivation-Behavioral Skills Analysis Advances Understanding of Barriers to Self-Monitoring of Blood Glucose
5. Reportlinker Adds Global Coronary Stents Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
6. Zargis to Launch FDA-Cleared Lung Sounds Analysis Technology from Stethographics, Inc.
7. Boehringer Ingelheim Affirms Safety of Telmisartan With an Analysis of 50,000 Patients and Strongly Disagrees With the Publication of Sipahi et al in Lancet Oncology June 2010
8. Genomic Health Announces Results From the Largest Genomic Analysis of Localized Clear Cell Renal Carcinoma at American Society of Clinical Oncology (ASCO) Annual Meeting
9. Reportlinker Adds The Future of Ophthalmology Therapeutics, Analysis and Market Forecasts to 2016 - Strategies to Counter Generic Erosion in Key Markets
10. Reportlinker Adds Global Renal Dialysis Equipment Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
11. Large Meta-Analysis Further Validates Benefit of Measuring Lp-PLA2 for Coronary Heart Disease and Ischemic Stroke Risk Assessment
Post Your Comments:
(Date:11/25/2015)... , Nov. 25, 2015  Linden Care, LLC, a ... treatment outcomes for patients suffering from chronic pain, said ... a Temporary Restraining Order (TRO) enjoining Express Scripts from ... companies. --> --> ... of its legal options. --> ...
(Date:11/25/2015)... USA , Inc., a leader in ... accuracy of its blood glucose meter systems. Last week ... Cardiovascular Disease in Los Angeles , ... 01 meter and the Assure ® Prism multi-user ... measure glucose levels in blood is essential for people ...
(Date:11/25/2015)... 25, 2015 Allergan plc (NYSE: AGN ) ... New York State Attorney General,s Office ... Act, and other statutes with the Attorney General over the ... cease marketing and selling the now generic version of memantine ... no liability, has released its counterclaims against New ...
Breaking Medicine Technology:
(Date:11/26/2015)... ... November 26, 2015 , ... ... located in central Michigan, have come together on Thanksgiving Day to share the ... available for viewing on the Serenity Point YouTube channel, patients displayed what they ...
(Date:11/26/2015)... and Cambridge, ON (PRWEB) , ... November 26, ... ... the availability of a real-time eReferral system for diagnostic imaging in the Waterloo ... X-rays, mammography, BMD and Nuclear Medicine tests directly from their electronic medical record ...
(Date:11/26/2015)... ... November 26, 2015 , ... ... to discuss bioavailability and the need to integrate dose form selection in early ... with OBN, the membership organization supporting and bringing together the UK’s emerging life ...
(Date:11/26/2015)... ... 2015 , ... PRMA Plastic Surgery is updating their record books yet again ... free flap breast reconstruction surgery! , “What an accomplishment for the PRMA team, says ... and it’s an honor to have served all of these women.” , PRMA is ...
(Date:11/26/2015)... Viejo, CA (PRWEB) , ... November 26, 2015 ... ... users a new set of retro-fused, self-animating trailer titles with ProTrailer: Vintage. This ... style options. These classically-influenced trailer titles work with any font, giving users limitless ...
Breaking Medicine News(10 mins):